Current Partnering Market Research Reports

TITLE Actions
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2015-2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements ente...

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides comprehensive understanding and unprecedented access to the joint venture deals and agreements entered into by the worlds leading li...

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading ...

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2016-2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2022 report provides comprehensive understanding and unprecedented access to the collaborative R&D deals and agreements entered into by the worlds le...

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010 - 2022 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and mi...

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fu...

Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 - 2022 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life sci...

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report. This report provides details of the latest manufacturing and supply agreements announced in the pharmaceutical, bio...

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2015-2022 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The report provides a de...

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report. This report provides details of the latest option and evaluation agreements announced in the pharmaceutical, biotechno...

Global Autoimmune Partnering 2015-2022: Deal trends, players and financials
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

Global Autoimmune Partnering 2015 to 2022 provides the full collection of Autoimmune disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Trends in Autoimmune partnering deals Financial d...

Global Cardiovascular Partnering 2015-2022: Deal trends, players and financials
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

Global Cardiovascular Partnering 2015 to 2022 provides the full collection of Cardiovascular disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Trends in Cardiovascular partnering deals...

Global Central Nervous System Partnering 2015-2022: Deal trends, players and financials
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

Global Central Nervous System Partnering 2015 to 2010 provides the full collection of Central Nervous System disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Trends in Central Nervous Syste...

Global Dental Partnering 2010-2022: Deal trends, players and financials
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

Global Dental Partnering 2010 to 2022 provides the full collection of Dental disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010. Trends in Dental partnering deals Financial deal terms fo...

Global Dermatology Partnering 2015-2022: Deal trends, players and financials
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

The Global Dermatology Partnering 2015-2022: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies. Tre...

Global Gastrointestinal Partnering 2015-2022: Deal trends, players and financials
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

Global Gastrointestinal Partnering 2015 to 2022 provides the full collection of Gastrointestinal disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Trends in Gastrointestinal partnering deals...

Global Genetic Disorders Partnering 2015-2022: Deal trends, players and financials
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

Global Genetic Disorders Partnering 2015 to 2022 provides the full collection of Genetic Disorders disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Trends in Genetic Disorders partnering de...

Global Coronavirus Partnering 2015-2022
Published in Apr 2022 | US $ 3495 Onwards | By Current Partnering

Global Coronavirus Partnering 2015 to 2022 provides the full collection of Coronavirus disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Trends in Coronavirus partnering deals Financia...

Global Genitourinary Partnering 2010-2021: Deal trends, players and financials
Published in Dec 2021 | US $ 3495 Onwards | By Current Partnering

Global Genitourinary Partnering 2010 to 2021 provides the full collection of Genitourinary disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010. Trends in Genitourinary partnering deals Fi...

Global Gynecology Partnering 2010-2021: Deal trends, players and financials
Published in Dec 2021 | US $ 3495 Onwards | By Current Partnering

Global Gynecology Partnering 2010-2021: Deal trends, players and financials provides the full collection of Gynecology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010. Trends in Gynecology ...

We are on:

Need Help?